Nom Action | Symbole Action | Marché | Type |
---|---|---|---|
Nymox Pharmaceutical Corp | NYMX | NASDAQ | Action ordinaire |
Ouverture | Plus Bas | Plus Haut | Prix de clôture | Clôture Veille |
---|---|---|---|---|
0,20 | 0,20 |
Actualités Recentes
Date | Heure | Source | Titre |
---|---|---|---|
28/3/2024 | 18:03 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
06/11/2023 | 15:59 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
08/9/2023 | 16:13 | EDGAR2 | Form 25-NSE - Notification filed by national security.. |
25/7/2023 | 22:04 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
25/7/2023 | 16:33 | GLOBE | Nymox Reports Successful New NYMOZARFEX (TM) Long-Term.. |
18/7/2023 | 16:45 | GLOBE | Nymox Reports on U.S. Patent Issuances |
13/7/2023 | 16:16 | GLOBE | Nymox Update |
12/7/2023 | 15:30 | GLOBE | Nymox Announces Appointment Of Patrick Doody as Vice.. |
07/7/2023 | 23:02 | GLOBE | NYMOX Update |
06/7/2023 | 00:11 | GLOBE | Nymox Delisting from NASDAQ |
29/6/2023 | 23:15 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
10/5/2023 | 16:00 | GLOBE | Nymox Provides Current Update |